AtaiBeckley (ATAI) Change in Acquisitions & Divestments (2022 - 2025)
AtaiBeckley (ATAI) posted Change in Acquisitions & Divestments of -$11.1 million for Q3 2025, down 200.0% sequentially from $11.1 million in Q2 2025, and up 85.12% YoY from -$6.0 million in Q3 2024.
Analysis
AtaiBeckley (ATAI) Change in Acquisitions & Divestments (2022 - 2025) Analysis & Trends
AtaiBeckley has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at -$11.1 million in Q3 2025.
- Quarterly Change in Acquisitions & Divestments rose 85.12% year-over-year to -$11.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $11.3 million (down 94.14% YoY) and the FY2024 annual result came in at $65.6 million, down 52.83% from the prior year.
- Change in Acquisitions & Divestments retreated to -$11.1 million in Q3 2025 per ATAI's latest filing, from $11.1 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $226.8 million in Q4 2022 and troughed at -$74.3 million in Q3 2024.
- A 4-year average of $39.2 million and a median of $17.7 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- The widest YoY moves for Change in Acquisitions & Divestments: up 377.87% in 2024, down 102.49% in 2024.
- Over 4 years, Change in Acquisitions & Divestments stood at $226.8 million in 2022, then sank by 38.94% to $138.5 million in 2023, then sank by 91.85% to $11.3 million in 2024, then tumbled by 197.95% to -$11.1 million in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered -$11.1 million, $11.1 million, and $11.3 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -11.06 Mn |
| Jun 30, 2025 | 11.06 Mn |
| Dec 31, 2024 | 11.29 Mn |
| Sep 30, 2024 | -74.35 Mn |
| Jun 30, 2024 | 84.78 Mn |
| Mar 31, 2024 | 43.84 Mn |
| Dec 31, 2023 | 8.62 Mn |
| Sep 30, 2023 | 93.16 Mn |
| Jun 30, 2023 | 17.74 Mn |
| Mar 31, 2023 | 19.46 Mn |
| Dec 31, 2022 | 226.83 Mn |